Related Experiment Video
Updated: Jun 23, 2026
06:38
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
Published on: August 4, 2022
A suppressive oligodeoxynucleotide inhibits ocular inflammation.
C Fujimoto1, D M Klinman, G Shi
1Laboratories of Immunology, National Eye Institute, NIH, Bethesda, MD 20892-1857, USA.
Clinical and Experimental Immunology
|May 15, 2009
Summary
Synthetic DNA (ODN) can suppress harmful immune responses. A151 ODN effectively reduced eye inflammation in mouse models, suggesting potential for treating autoimmune ocular diseases.
Area of Science:
- Immunology
- Ophthalmology
- Pharmacology
Background:
- Synthetic oligodeoxynucleotides (ODN) with TTAGGG motifs can modulate immune responses.
- Proinflammatory and T helper type 1 (Th1)-mediated immune responses contribute to various pathological conditions.
- Ocular inflammation, particularly autoimmune uveitis, presents a significant therapeutic challenge.
Purpose of the Study:
- To investigate the efficacy of a suppressive ODN, A151, in mitigating ocular inflammation.
- To evaluate A151's effects in two distinct murine models of ocular inflammation.
- To determine if A151 impacts both the initiation and progression of autoimmune ocular disease.
Main Methods:
- Utilized experimental autoimmune uveitis induced by interphotoreceptor retinoid-binding protein (IRBP) immunization in mice.
- Employed an adoptive transfer model of ocular inflammation using Th1 cells specific to hen egg lysozyme (HEL).
- Administered A151 ODN to evaluate its therapeutic effects on established ocular inflammation and immune cell responses.
Main Results:
- A151 treatment significantly suppressed ocular inflammation in both experimental autoimmune uveitis and adoptive transfer models.
- A151 inhibited the production of IRBP-specific cytokines in immunized mice.
- Lymphocyte proliferation in response to IRBP antigen was also suppressed by A151 treatment.
Conclusions:
- Suppressive ODN, exemplified by A151, demonstrates potent anti-inflammatory effects in autoimmune ocular disease models.
- A151 appears to act on both the afferent (induction) and efferent (effector) phases of the immunopathogenic process.
- These findings highlight the therapeutic potential of suppressive ODN for treating autoimmune ocular inflammation.
Related Concept Videos
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...